InvestorsHub Logo
Followers 164
Posts 36254
Boards Moderated 2
Alias Born 10/20/2019

Re: diskman post# 11831

Monday, 01/24/2022 2:35:59 PM

Monday, January 24, 2022 2:35:59 PM

Post# of 13742
$QNTA trading low volume with little BID support in spite of the great News last week...

Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of the Company’s product, Escozine, as a COVID-19 treatment. The product, which is registered as an alternative oncological medicine in the DR, has shown to be effective against variations of the SARS-CoV-2 virus.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.